4.8 Article

Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells

Journal

CELL REPORTS
Volume 25, Issue 13, Pages 3674-+

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2018.11.103

Keywords

-

Categories

Funding

  1. Breast Cancer Now [2012MayPR076, 2012MaySF122, 2013NovPhD184]
  2. Breast Cancer Research Aid
  3. Wales Cancer Research Centre
  4. Cancer Research UK [CRUK/A15938]
  5. European Cancer Stem Cell Research Institute
  6. Cardiff University
  7. Cancer Research UK
  8. MINECO/FEDER, EU [SAF2017/84934/R]
  9. Centro Excelencia Severo Ochoa-Agencia Estatal de Investigacion [SEV-2016-0644]
  10. Breast Cancer Now

Ask authors/readers for more resources

The SRC-family kinase LYN is highly expressed in triple-negative/basal-like breast cancer (TNBC) and in the cell of origin of these tumors, c-KIT-positive luminal progenitors. Here, we demonstrate LYN is a downstream effector of c-KIT in normal mammary cells and protective of apoptosis upon genotoxic stress. LYN activity is modulated by PIN1, a prolyl isomerase, and in BRCA1 mutant TNBC PIN1 upregulation activates LYN independently of c-KIT. Furthermore, the full-length LYN splice isoform (as opposed to the Delta aa25-45 variant) drives migration and invasion of aggressive TNBC cells, while the ratio of splice variants is informative for breast cancer-specific survival across all breast cancers. Thus, dual mechanisms-uncoupling from upstream signals and splice isoform ratios-drive the activity of LYN in aggressive breast cancers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available